Skip to content

    Recently Viewed


      Home / Our Company / Discover J&J / Our leadership team /
      Jennifer A. Doudna, Ph.D.
      A headshot of  Jennifer A. Doudna, Ph.D. in a black top
      Our Leadership Team

      Jennifer A. Doudna, Ph.D.

      Professor of Chemistry; Professor of Biochemistry & Molecular Biology; Li Ka Shing Chancellor’s Professorship in Biomedical and Health, University of California, Berkeley

      Dr. Doudna, age 59, joined the faculty at University of California, Berkeley, as a Professor of Biochemistry & Molecular Biology in 2002. She directs the Innovative Genomics Institute, a joint UC Berkeley-UC San Francisco center, holds the Li Ka Shing Chancellor’s Professorship in Biomedical and Health, and is the Chair of the Chancellor’s Advisory Committee on Biology at UC Berkeley. Dr. Doudna is Principal Investigator at the Doudna Lab at UC Berkeley and has founded and serves on the Scientific Advisory Boards of Caribou Biosciences, Inc. and Intellia Therapeutics, Inc., both leading CRISPR genome engineering companies. She has been an Investigator with the Howard Hughes Medical Institute since 1997. Dr. Doudna is the recipient of numerous scientific awards in biochemistry and genetics, including the Nobel Prize in Chemistry in 2020. Dr. Doudna is a Trustee for Pomona College.

      Skills and Qualifications

      • Pioneer in the field of biochemistry, having co-discovered the simplified genome editing technique CRISPR-Cas9
      • Expertise in scientific research and innovation
      • Leader in integration of scientific research and ethics

      Current Committees

      • Member, Nominating & Corporate Governance
      • Member, Science & Technology

      Other Public Board Service

      • None

      Board of Directors

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.